Head of Investor Relations
Ascentage Pharma Group International (AAPG)Equibles does not estimate personal net worth.
Get an email with a short summary when Ascentage Pharma Group International publishes a filing, an earnings call transcript or a press release.
Get AAPG alertsSumed Sunkarineni is recorded as Head of Investor Relations at Ascentage Pharma Group International (AAPG). Sumed Sunkarineni has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Ascentage Pharma Group International on August 20, 2026. Ascentage Pharma Group International is classified in the Biotechnology industry within the Healthcare sector.
“Please note that today's discussion will include forward-looking statements based on our current expectations and assumptions. These statements involve risks and uncertainties, and actual results may differ materially.”
“Please note that today's discussion will include forward-looking statements based on our current expectations and assumptions. These statements involve risks and uncertainties, and actual results may differ materially.”
Head of Investor Relations
Transcript header (unverified)
Biotechnology · Healthcare
Head of Investor Relations
